ASX Announcements

25th Jul Quarterly Review
24th Jul Completion of THC Agreements
23rd Jul Notice of General Meeting/Proxy Form
16th Jul Update by Eagle Health on Chinese Market
3rd Jul Update on THC Agreements
21st Jun EVE to Acquire Leading Australian Organic Tea Tree Oil Producer
19th Jun Trading Halt
31st May Eagle Plans to Significantly Expand China Distribution
29th May Corporate Update
3rd May Meluka Health and THC Execute Term Sheet
30th Apr Quarterly Review
26th Apr First Quarter China Sales Progress
5th Apr Net Tangible Asset Backing
4th Apr Appendix 3B
4th Apr Change of Director's Interest Notice x 4
28th Mar Allotment of Rights Issue Shortfall
14th Mar Net Tangible Asset Backing
14th Mar Investor Presentation
6th Mar Completion of Rights Issue
26th Feb Half Yearly Report and Accounts
23rd Feb Meluka Honey Consumer Products Launch at US Natural Products Expo
19th Feb Rights Issue Offer Document
14th Feb Omni Innovation Update by Eagle on Chinese Rollout
13th Feb Eagle Commences Marketing and Sales in China
13th Feb Net Tangible Asset Backing
12th Feb Letter to Shareholders
9th Feb Letter to Optionholders
9th Feb Pro-Rata Non-Renounceable Rights Offer
9th Feb Appendix 3B and Section 708AA(2)(f) Notice
8th Feb Appendix 3B
7th Feb Appendix 3B
6th Feb Capital Raising Update
6th Feb Prospectus
31st Jan Oversubscribed Placement and Rights Issue to Raise up to $6.3m
31st Jan Change to Board Roles
31st Jan Quarterly Review
31st Jan Appendix 3B
25th Jan Trading Halt
18th Jan Appendix 3B

Adobe Acrobat Reader 5.0 or later needed to view PDF files. Get Acrobat Reader